Locations:
Search IconSearch

Hands-on HIPEC Course and Anatomy Lab

Don’t miss this educational opportunity

HIPEC_650x450

Publication of a randomized trial in the New England Journal of Medicine demonstrating that hyperthermic intraperitoneal chemotherapy (HIPEC) during interval cytoreduction in women with advanced ovarian cancer improves both progression-free and overall survival has sparked interest among centers that treat ovarian cancer. A number of centers are initiating HIPEC programs.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

June 21-22 course on HIPEC

If you are practicing at one of these centers or have interest in HIPEC, the fast-approaching “Hands-on HIPEC Course and Anatomy Lab” will be of interest. The course will take place June 21-22, 2018, at Cleveland Clinic.

Among largest HIPEC programs in U.S.

Cleveland Clinic Ob/Gyn & Women’s Health Institute, which managed more than 140 ovarian cancer surgical cases in 2017, has offered HIPEC to select patients with advanced and recurrent ovarian cancer for four years, under the leadership of gynecologic oncologist Robert DeBernardo, MD. Dr. DeBernardo, established the HIPEC program four years ago and has led it since. He is Director of Minimally Invasive Surgery for the institute and Director of the Peritoneal Surface Malignancy Program.

“Because of ongoing treatment challenges in ovarian cancer, we are encouraged by results from the latest clinical trial of HIPEC,” Dr. DeBernardo says. “Our hope is to share our experience and help newer programs understand which patients may benefit from HIPEC and how to safely administer this promising therapy.” HIPEC is only effective in patients who have minimal or no residual disease after surgery, he adds. With well over 100 patients treated, Cleveland Clinic has one of the country’s largest experiences using HIPEC for ovarian cancer.

The 1-1/2 day course will include these sections:

  • lecture
  • cadaver lab
  • live surgical demonstration

Topics to be covered:

  • current data on HIPEC in women with gynecologic cancer
  • patient selection
  • chemotherapy protocols
  • intraoperative management/anesthesia concerns
  • surgical technique

Advertisement

All participants will receive a certificate of completion to use at their institution for credentialing purposes.

For more information call 216.444.7645, or go to clevelandclinic.org/HIPECcourse to register. Space in this course is limited.

Advertisement

Related Articles

woman holding GLP1 injection pen

Preconception GLP-1 Use Not Linked to Higher Pregnancy Risk

Data point to potential for targeted preconception planning

Pregnant woman holding pill

Psychoactive Drug Patterns Before, During and Just After Pregnancy

Reproductive psychiatry helps patients balance medication-related risks

illustration of endometrial cancer

Endometrial Cancer Staging Updates Reflect Molecular Profiling

Molecular Profiles Help Guide Referral and Care Planning

Doctor scrubbing before surgery

Expanding HIPEC for Ovarian Cancer Through Hands-On Training

Hyperthermic intraperitoneal chemotherapy can improve patient outcomes

Woman holding birth control pill

Sexual Healthcare for Cancer Survivors

Leaning into therapies with the strongest evidence

Picture of Dr. Isaacson

Why Young People Need Specialized Gynecologic Care

A Q&A with Cleveland Clinic’s board-certified pediatric and adolescent gynecologist

Young girl on a medical exam bench

What a Strong Performance on Single HPV Dose Means for Clinical Conversations

Increasing uptake remains a challenge

medical team surrounding a hospital bed with a "pregnant" medical manikin

Ob/Gyn Simulation Training Can Be a Key Quality and Safety Tool

Multidisciplinary teams work together in in-situ scenarios

Ad